Skip to content

Inspection Record

Samsung Biologics Co., Ltd. — FDA 483 Findings

US FDAInspected 2025-05-27Published 2026-10-26 4 findingsLaboratory and QC controlsRegulatory reporting and change controlContamination controlQuality unit oversight

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

Procedures and controls utilized within the Quality Control (QC) Laboratory in support of drug substance release and(b) (4)testing are deficient.

2Regulatory reporting and change control

Failure to follow established procedures for reporting and implementing changes to an approved application.

3Contamination control

Procedures implemented to prevent cross-contamination of drug substances during product change over (PCO) operations were not followed.

4Quality unit oversight

The responsibilities and procedures applicable to the quality control unit were not followed.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Samsung Biologics Co., Ltd. findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.